Afatinib 

Afatinib, a second-generation tyrosine kinase inhibitor, is employed in the treatment of non-small cell lung cancer (NSCLC). As an irreversible inhibitor of the epidermal growth factor receptor (EGFR) family, it hinders cancer cell growth by blocking critical signaling pathways. Specifically prescribed for patients with certain EGFR mutations, afatinib has shown efficacy in enhancing progression-free survival. Buy high quality Afatinib from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Afatinib

CAT. No.:CP-A50000

CAS. No.:850140-72-6

Mol. F.:C24H25ClFN5O3

Mol. Wt.:485.96

Stock Status:Custom Synthesis

Rel. Cas No:1398312-49-6(HClsalt);1398312-36-1(Sulfatesalt);850140-73-7(Dimaleatsalt)

Synonyms:Gilotrif ; Tovok

Chemical Name:(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide

견적 문의: aibiohub@aibiohub.co.kr  홈페이지: www.aibiohub.co.kr 

견적 문의: https://aibiohub.co.kr/estimate/write